BioSpace News Archive

Biotech Bay

Adicet Bio to Participate in a Fireside Chat at the 2023 Jefferies Healthcare Conference

Adicet Bio, Inc. today announced that Chen Schor, President and Chief Executive Officer, will participate in a fireside chat at the Jefferies Healthcare Conference being held from June 7-9, 2023 in New York.

June 1, 2023
·
1 min read
Pharm Country

MindMed to Participate at Upcoming Investor Conferences

Mind Medicine announced today that members of the Company’s management team will participate in the following investor conferences.

June 1, 2023
·
1 min read
BioMidwest

Xeris Biopharma to Participate at the Jefferies Healthcare Conference

Xeris Biopharma Holdings, Inc. today announced that members of its senior management will participate in a fireside chat at the Jefferies Healthcare Conference on Thursday, June 8 at 10:30am Eastern Time.

June 1, 2023
·
1 min read
Business

LYNPARZA® (olaparib) plus abiraterone approved in the US for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer

LYNPARZA ® (olaparib) plus abiraterone approved in the US for the treatment of BRCA -mutated metastatic castration-resistant prostate cancer.

June 1, 2023
·
25 min read
Genetown

Dyne Therapeutics to Present at Jefferies Healthcare Conference

Dyne Therapeutics, Inc today announced that management is scheduled to participate in a fireside chat at the Jefferies Healthcare Conference in New York on Thursday, June 8, 2023 at 2:00 p.m. ET.

June 1, 2023
·
1 min read
Business

Lifecore Biomedical Reports Third Quarter Fiscal Year 2023 Results

Lifecore Biomedical, Inc., a fully integrated contract development and manufacturing organization, reported results for the fiscal 2023 third quarter ended February 26, 2023.

June 1, 2023
·
24 min read
Deals

Lyra Therapeutics Announces Closing of $50.0 Million Private Placement

Lyra Therapeutics, Inc. today announced the closing of its previously announced private placement of common stock, pre-funded warrants to purchase common stock and purchase warrants to purchase common stock, resulting in gross proceeds of approximately $50.0 million.

June 1, 2023
·
7 min read
Biotech Bay

Ivonescimab Updated Data to be Featured at ASCO 2023

Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that data for its novel, potential first-in-class investigational bispecific antibody, ivonescimab, will be presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL.

June 1, 2023
·
9 min read
Genetown

Oculis Announces Pricing of $40.25 Million Public Offering of Ordinary Shares

Oculis Holding AG announced the pricing of a follow-on public offering of 3,500,000 ordinary shares at a public offering price of $11.50 per ordinary share, for gross proceeds of $40.25 million, before deducting underwriting discounts and commissions and offering expenses.

June 1, 2023
·
4 min read
Pharming announces sale of priority review voucher

Pharming Group N.V. announces that it has entered into a definitive agreement with Novartis Pharma A.G. to sell its Rare Pediatric Disease Priority Review Voucher to Novartis for a pre-agreed, one-time payment of approximately US$21.1 million shortly after closing.

June 1, 2023
·
5 min read